Medicina de Família

Se exposto ao Covid-19, quanto tempo até apresentar sintomas? O tempo de incubação médio é de 5,1 dias e 97,5% daqueles que desenvolvem sintomas o fazem em 11,5 dias após expostos ao vírus

8 Dez, 2020 | 05:04h

If Exposed To Covid-19 Coronavirus, How Long Before You Have Symptoms – Forbes

 

---

Opinião: Estejam prontos para falsos efeitos adversos relacionados às vacinas. Quando se vacina milhões de pessoas, problemas de saúde que ocorreriam naturalmente poderão ser atribuídos erroneamente às vacinas

8 Dez, 2020 | 04:52h

Get Ready for False Side Effects – Science Translational Medicine

 

---

O uso de espironolactona está associado a melhora nos desfechos em pacientes com insuficiência cardíaca com fração de ejeção preservada e hipertensão resistente concomitante

8 Dez, 2020 | 04:41h

Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension – Journal of the American Heart Association

Comentário: Spironolactone use associated with improved outcomes for patients with HFpEF and resistant hypertension – 2 Minute Medicine

 

---

Estudo observacional: Corticoides orais em baixas doses estão associados a aumento no risco cardiovascular em pessoas com doenças inflamatórias imunomediadas

8 Dez, 2020 | 04:37h

Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study – PLOS Medicine

Comentário: Patients receiving low dose steroid at increased risk of cardiovascular disease – Public Library of Science

 

---

Estudo randomizado em mulheres gestantes com hipertensão leve a moderada mostrou que o uso de labetalol foi associado a maior risco de complicações quando comparado a metildopa ou tratamento controle

8 Dez, 2020 | 04:28h

Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial – Hypertension in Pregnancy

Comentário: Methyldopa versus labetalol or no medication for the treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial – Physician’s Weekly

 

---

Novas Diretrizes do CDC com 10 medidas de saúde pública essenciais para reduzir a transmissão do SARS-Cov-2, incluindo o uso universal de máscaras

6 Dez, 2020 | 22:09h

Summary of Guidance for Public Health Strategies to Address High Levels of Community Transmission of SARS-CoV-2 and Related Deaths, December 2020 – CDC Morbidity and Mortality Weekly Report

Comentários: Masks are critical to stopping coronavirus spread, even at home, CDC says – CNN AND CDC recommends ‘universal’ use of face masks to prevent COVID-19 spread – UPI

 

Comentário no Twitter

In most of the US, Covid transmission is at dangerously high levels. CDC released a new package of 10 key strategies needed to curb the spread, including universal masking and postponing travel. https://t.co/b0utHmygSI pic.twitter.com/HXjlo89WrR

— Dr. Tom Frieden (@DrTomFrieden) December 5, 2020

 

---

Meta-análise: Função respiratória pós-infecção por COVID-19. Capacidade de difusão alterada, padrão restritivo e padrão obstrutivo foram encontrados em 39%, 15% e 7% dos pacientes, respectivamente

6 Dez, 2020 | 22:02h

Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis – Pulmonology

 

Comentário no Twitter

Check out our recent systematic review in post-COVID-19 patients. Altered diffusion capacity, restrictive pattern and obstructive pattern were found in 39%, 15% and 7% of patients, respectively. @VilaroJordi @lvasconcello @RestoyAlsina @BufadorBufador https://t.co/PDHcUOCEbw

— Rodrigo Torres Castro (@klgorodtorres) November 25, 2020

 

---

Estudo na Alemanha comparando regiões com obrigatoriedade de máscaras vs. regiões sem obrigatoriedade concluiu que 20 dias após as máscaras se tornarem mandatórias houve uma redução estimada de 45% no número de novas infecções por Covid-19

6 Dez, 2020 | 21:48h

Face masks considerably reduce COVID-19 cases in Germany – Proceedings of the National Academy of Sciences

 

---

Estudo randomizado: Vacina contra influenza em alta dose não traz benefícios adicionais em pacientes com insuficiência cardíaca

6 Dez, 2020 | 21:42h

Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial – JAMA

Editorial: Influenza Vaccine for Patients With High-risk Cardiovascular Disease

Comentário: High-dose influenza vaccine shows no additional benefit for heart disease patients – NIH News Releases

 

Comentário no Twitter

In patients w high-risk CVD, high-dose trivalent influenza vaccine, vs standard-dose quadrivalent vaccine, did not significantly reduce all-cause mortality or cardiopulmonary hospitalizations https://t.co/I3XygBajQL

— JAMA (@JAMA_current) December 4, 2020

 

---

Estudo de caso-controle: Vacina Meningocócica B previna a doença com 79% de efetividade em crianças e adultos jovens

6 Dez, 2020 | 21:40h

Association of Use of a Meningococcus Group B Vaccine With Group B Invasive Meningococcal Disease Among Children in Portugal – JAMA

Comentário: Meningococcus B vaccine prevents disease with 79 per cent effectiveness in under-18s – University of Bristol

 

Comentário no Twitter

In this matched case-control study, children who developed meningococcal disease were less likely to have been vaccinated with 4CMenB vs matched controls without meningococcal disease during the first 5y of vaccine availability in Portugal https://t.co/dGagZ3aTIB @adamhfinn

— JAMA (@JAMA_current) December 3, 2020

 

---